Maximus Reports Quarterly Growth Amid Cash Flow Challenges and Divestiture Impacts

Maximus, Inc. (NYSE: MMS) has reported its quarterly results for the period ended March 31, 2025. The company engaged in several activities and strategic decisions impacting its performance, which we summarize below.

Positive Aspects:

• Revenue Growth: Maximus recorded revenues of $1,361.8 million for Q2 2025, up from $1,348.4 million in Q2 2024, reflecting a growth of 1.0%.
• Gross Profit Increase: Gross profit increased to $338.8 million (24.9% margin), compared to $317.6 million (23.6% margin) year-over-year, indicating improved profitability.
• Operating Income: Operating income rose to $153.0 million, representing an 11.2% margin, up from $127.5 million (9.5% margin) in the prior-year quarter.
• Net Income: The company reported a net income of $96.6 million, a substantial increase from $80.5 million in Q2 2024.
• Strong Demand: Revenue growth is attributed to increased volumes in clinical programs, particularly medical assessments for veterans under the PACT Act.

Negative Aspects:

• Cash Flow Challenges: Maximus experienced net cash used in operations of $37.3 million in the first six months of 2025, compared to cash provided by operations of $152.1 million in 2024, highlighting cash flow difficulties.
• Divestiture Impact: The divestiture of businesses in Australia and Korea has affected revenues and profitability, with a reported $39.3 million in related charges impacting SG&A expenses.
• Higher Interest Expense: Interest expense rose slightly to $21.5 million from $20.4 million, contributing to overall financing costs amidst an increase in overall debt levels.
• Declining Customer Revenue: U.S. Services segment revenue declined 9.0% year-over-year to $442.4 million, indicative of challenges in state and local government contracts.

Key Financial Statistics:

• Q2 Revenue: $1,361.8 million (vs. $1,348.4 million)
• Gross Profit: $338.8 million (24.9% margin)
• Operating Income: $153.0 million (11.2% margin)
• Net Income: $96.6 million
• Earnings Per Share (Diluted): $1.69
• Total Debt: $1.506 billion
• Cash and Cash Equivalents: $108.1 million

Maximus continues to navigate a complex landscape influenced by government spending, legislative changes, and its restructuring initiatives. The company aims to capitalize on organic growth opportunities while addressing cash flow management and operational efficiency to ensure ongoing profitability.